The ALS Drug Development Summit is a scientific conference that brings together leaders from biotech, pharma, academia and advocacy groups to accelerate the development of therapies for ALS and related conditions. It focuses on collaboration, sharing research insights and advancing clinical and translational strategies to improve patient outcomes.

Date: June 2-4, 2026
Location: Boston, Massachusetts, USA
https://als-drug-development.com/

JOIN US!

Join us at the ALS Drug Development Summit to learn how Catalent can support your drug development journey with our Zydis® ODT technology, which advances patient-centric therapies through enhanced ease of administration and improved adherence. Schedule a meeting today!

Complete the form to schedule a meeting with our experts!

ABOUT CATALENT

Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) championing the missions that help people live better and healthier lives. Every product that Catalent helps develop, manufacture and launch reflects its commitment to improve health outcomes around the world through its Patient First approach. Catalent provides unparalleled service to pharma, biotech and consumer health customers, delivering on their missions to transform lives. Catalent tailors end-to-end solutions to meet customers’ needs in all phases of development and manufacturing. With thousands of scientists and technicians and the latest technology platforms at nearly 40 global sites, Catalent supplies billions of doses of life-enhancing and life-saving treatments for patients annually. For more information, visit www.catalent.com.

 

Championing the missions that matter™